BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35201650)

  • 1. Prostate biopsy and prostate cancer management in patients with haemophilia: The experience of French Haemophilia Treatment Centres.
    Gautier P; Guillet B; Sigaud M; Claeyssens S; Volot FG; Chamouni P; Lienahrt A; Frotscher B; Fournel A; Castet S; Poumayou C; Gay V; Thuret R; Wibaut B; Biron-Andreani C
    Haemophilia; 2022 May; 28(3):437-444. PubMed ID: 35201650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer detection and management in patients with haemophilia: a retrospective European multicentre study.
    Biron-Andreani C; de Moerloose P; D'oiron R; Chambost H; Schved JF; Hermans C
    Haemophilia; 2014 Jan; 20(1):78-82. PubMed ID: 23919383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parameters.
    Tuinenburg A; Biere-Rafi S; Peters M; Verhamme P; Peerlinck K; Kruip MJ; Laros-Van Gorkom BA; Roest M; Meijers JC; Kamphuisen PW; Schutgens RE
    Haemophilia; 2013 Sep; 19(5):744-52. PubMed ID: 23659471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011385. PubMed ID: 31002742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to prophylaxis and bleeding outcome in haemophilia: a multicentre study.
    Schrijvers LH; Beijlevelt-van der Zande M; Peters M; Lock J; Cnossen MH; Schuurmans MJ; Fischer K
    Br J Haematol; 2016 Aug; 174(3):454-60. PubMed ID: 27098446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of haemophilia, including prophylaxis, constant infusion and DDAVP.
    Berntorp E
    Baillieres Clin Haematol; 1996 Jun; 9(2):259-71. PubMed ID: 8800504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The one-stage assay or chromogenic assay to monitor baseline factor VIII levels and desmopressin effect in non-severe haemophilia A: Superiority or non-inferiority?
    Schütte LM; Hodes LS; van Moort I; Stoof SCM; Leebeek FWG; Cnossen MH; de Maat MPM; Kruip MJHA
    Haemophilia; 2020 Sep; 26(5):916-922. PubMed ID: 32713129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The profile of patients with haemophilia managed at a haemophilia treatment centre in Pretoria, Gauteng.
    Mafisa L; Dlova AN; Moodley V
    S Afr Fam Pract (2004); 2022 Oct; 64(1):e1-e7. PubMed ID: 36331203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate interventions in patients with mild haemophilia: Safe and feasible.
    Mesnard B; Drillaud N; Sigaud M; Hakim G; Chelly S; Ternisien C; Fouassier M; Chelghaf I; De Vergie S; Perrouin Verbe MA; Rigaud J; David A; Trossaërt M; Branchereau J
    Haemophilia; 2021 Nov; 27(6):e659-e666. PubMed ID: 34342928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild haemophilia: a disease with many faces and many unexpected pitfalls.
    Peerlinck K; Jacquemin M
    Haemophilia; 2010 Jul; 16 Suppl 5():100-6. PubMed ID: 20590864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening urinalysis demonstrates that haematuria is a frequent finding in persons with haemophilia treated at a paediatric haemophilia treatment centre.
    Davis KA; Stanek JR; Dunn AL
    Haemophilia; 2019 Sep; 25(5):782-788. PubMed ID: 31291048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases.
    Mannucci PM; Ruggeri ZM; Pareti FI; Capitanio A
    Lancet; 1977 Apr; 1(8017):869-72. PubMed ID: 67283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Life-threatening bleeding in patients with hemophilia (PWH): a 10-year cohort study in Dakar, Senegal.
    Touré SA; Seck M; Sy D; Bousso ES; Faye BF; Diop S
    Hematology; 2022 Dec; 27(1):379-383. PubMed ID: 35306964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmopressin is not always effective in mild haemophilia A patients undergoing urological surgery: the need of standardized protocols.
    Renom P; Wibaut B; Rigot JM; Coupez B; Goudemand J
    Haemophilia; 2002 Sep; 8(5):711-4. PubMed ID: 12199685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A.
    Leissinger C; Becton D; Cornell C; Cox Gill J
    Haemophilia; 2001 May; 7(3):258-66. PubMed ID: 11380629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study.
    Schütte LM; Cnossen MH; van Hest RM; Driessens MHE; Fijnvandraat K; Polinder S; Beckers EAM; Coppens M; Eikenboom J; Laros-van Gorkom BAP; Meijer K; Nieuwenhuizen L; Mauser-Bunschoten EP; Leebeek FWG; Mathôt RAA; Kruip MJHA
    BMJ Open; 2019 Apr; 9(4):e022719. PubMed ID: 31015264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we compare haemophilia carriers with clotting factor deficiency to male patients with mild haemophilia?
    Raso S; Lambert C; Boban A; Napolitano M; Siragusa S; Hermans C
    Haemophilia; 2020 Jan; 26(1):117-121. PubMed ID: 31815335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Antithrombotic Treatments Prescribed for Cardiovascular Diseases in Patients with Hemophilia: Results from the French Registry.
    Guillet B; Cayla G; Lebreton A; Trillot N; Wibaut B; Falaise C; Castet S; Gautier P; Claeyssens S; Schved JF
    Thromb Haemost; 2021 Mar; 121(3):287-296. PubMed ID: 33099283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of haemostatic drugs in haemophilia: desmopressin and antifibrinolytic agents.
    Villar A; Jimenez-Yuste V; Quintana M; Hernandez-Navarro F
    Haemophilia; 2002 May; 8(3):189-93. PubMed ID: 12010409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.